Form 8-K - Current report:
SEC Accession No. 0001213900-25-079167
Filing Date
2025-08-21
Accepted
2025-08-21 08:00:35
Documents
13
Period of Report
2025-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0253946-8k_ispecimen.htm   iXBRL 8-K 25376
2 PRESS RELEASE DATED AUGUST 21, 2025 ea025394601ex99-1_ispecimen.htm EX-99.1 12042
  Complete submission text file 0001213900-25-079167.txt   208865

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ispc-20250821.xsd EX-101.SCH 3017
4 XBRL LABEL FILE ispc-20250821_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE ispc-20250821_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0253946-8k_ispecimen_htm.xml XML 3782
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 251238416
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)